Recent Updates
Recently added Catalysts
BCRX Positive Sentiment Score: 70/100

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

Key Takeaway: BioCryst Pharmaceuticals, Inc. has announced its participation at the 44th Annual J.P. Morgan Healthcare Conference, which is scheduled for January 12, 2026. The presentation will take place at 1:30 p.m. ET and will be available for live audio webcast. This event is significant for BioCryst as it represents an opportunity to engage with investors and share updates on its progress.

Market Sentiment Analysis

POSITIVE FACTORS

  • BioCryst will showcase its latest developments at a major healthcare conference.
  • The participation in the J.P. Morgan Healthcare Conference highlights BioCryst's ongoing engagement with investors.
  • The live audio webcast allows for wide access to the presentation, promoting transparency.

Full Press Release Details

RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 1:30 p.m. ET.
A link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals

Frequently Asked Questions

When will BioCryst present at the J.P. Morgan Healthcare Conference?

BioCryst will present on January 12, 2026, at 1:30 p.m. ET.

Where can I find the live audio webcast of the presentation?

The live audio webcast can be accessed on BioCryst’s website.

What is the Nasdaq symbol for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals is listed under the Nasdaq symbol BCRX.

What type of company is BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals is a biopharmaceutical company.

Last updated: Jan 6, 2026